Long-Term Care Pharmacy Leaders Request Urgent COVID-19 Relief from Congressional Leaders
Letter to Congress Requests Immediate Action to Provide Relief for LTC Pharmacies Serving Most Vulnerable Patients in Nursing Homes, Other LTC Facilities
Washington, DC – Leaders from 12 of the largest long-term care (LTC) pharmacies in the country, representing more than 25% of the LTC pharmacy sector, have sent a letter to Congressional leadership requesting $350 million in desperately needed financial relief to meet the challenges imposed by the current unprecedented COVID-19 health crisis. These companies are all members of the Senior Care Pharmacy Coalition (SCPC), which represents 75% of the sector.
Citing dramatic revenue losses and higher costs due to the pandemic, the letter notes that LTC pharmacies “cannot be silent about the outsized impacts the pandemic has had on our sector and our need for immediate relief to fulfill this nation’s promise to our most vulnerable citizens.”
Approximately two million Americans in LTC facilities rely on LTC pharmacies to manage and deliver 12 to 13 different medications a day to each resident. Federal law specifically requires that LTC pharmacies provide health care services to these residents because getting medication management right is essential to their personal health and the quality of care provided. LTC pharmacies are an important behind-the-scenes partner for LTC providers who ensure that residents are receiving the best possible care.
“The financial situation for LTC pharmacies mirrors the financial situation for nursing homes and assisted living facilities,” noted SCPC President and CEO, Alan Rosenbloom.
Under the CARES Act, the Department of Health and Human Services (HHS) has given substantial and well-deserved financial relief to nursing homes and is working on additional relief for assisted living facilities. To date, however, HHS has provided only limited relief to LTC pharmacies and, in June, created new obstacles to relief for LTC pharmacies.
“Congress must address this issue promptly to ensure LTC pharmacies have access to the relief they need,” concluded Rosenbloom. “The absence of this timely, consistent pharmacy support from LTC pharmacies would make the dire circumstances LTC facilities continue to work through much worse.”
# # #
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.